Methods For Obtaining Liquid From A Solid Phase - EP2825646

The patent EP2825646 was granted to Cambridge Enterprise on Aug 7, 2019. The application was originally filed on Mar 15, 2013 under application number EP13717812A. The patent is currently recorded with a legal status of "Revoked".

EP2825646

CAMBRIDGE ENTERPRISE
Application Number
EP13717812A
Filing Date
Mar 15, 2013
Status
Revoked
Jan 12, 2024
Grant Date
Aug 7, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

QIAGENMay 7, 2020KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2008221372
EXAMINATIONUS6706858
INTERNATIONAL-SEARCH-REPORTWO2010108971
INTERNATIONAL-SEARCH-REPORTWO2012007502
OPPOSITIONEP1256627
OPPOSITIONEP2607482
OPPOSITIONUS2005244882
OPPOSITIONUS5411876
OPPOSITIONUS6383393
OPPOSITIONUS6706858
OPPOSITIONWO2005012523
OPPOSITIONWO2005070545
OPPOSITIONWO2010108971
OPPOSITIONWO9859076
OPPOSITIONWO9929840
OTHERUS2008221372
OTHERUS6706858

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "BIOROBOT MDx", QIAGEN - User Manual, (20020700), XP055701424
OPPOSITION- Anonymous, "Guidelines for processing the QIAamp® DNA Blood BioRobot® MDx Kit on the epMotion® 5075 VAC workstation", Eppendorf, (20050000), pages 1 - 17, XP055701427
OPPOSITION- Anonymous, "QIAamp® DNA Blood BioRobot MDx Kit Handbook Sample & Assay Technologies", QIAGEN, XP055701405
OPPOSITION- Anonymous, "QIAamp® Investigator BioRobot® Kit", QIAGEN - Handbook, (20080900), pages 1 - 44, XP055701706
OPPOSITION- Anonymous, "QIAGEN BioRobot 8000", QIAGEN - Handbook, (20021100), page 3-17, XP055701710
OPPOSITION- Anonymous, "RNeasy® 96 BioRobot 8000", Qiagen - Handbook, (200610), XP055701679
OPPOSITION- Anonymous, "RNeasy® Micro", Qiagen - Handbook, (20030400), pages 1 - 76, XP055701688
OPPOSITION- Anonymous, "Top Elute Fluid", QIAGEN - Material Safety Data Sheet, (20020804), pages 1 - 4, XP055701420
OPPOSITION- "Elution", Falbe J. et al, Römpp Lexicon. 10. Auflage, Thieme, (1996), page 1142, XP055701695
OPPOSITION- THURMAN et al., "Comparison of Laboratory Diagnostic Procedures for Detection of Mycopasma pneumoniae in Community Outbreaks", Clinical Infectious Diseases, (20090501), vol. 48, no. 9, pages 1244 - 1249, XP055701435

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents